NICE Snub to Glivec, a Rare Cancer Drug

The National Institute for Health and Clinical Excellence (NICE) … has stated that the cancer drug, Glivec (imatinib), recommended for treating gastrointestinal stromal tumours would no longer be used on NHS, as it failed to possess evidences regarding its long-term effectiveness.
TopNews